Agentix Corp. (AGTX)
Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Agentix Corp.
OTC:AGTXHealthcare · Biotechnology
-24.29%$0.0530
Mkt Cap$2.12M
Float9.95M
O/S40.07M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$486K
Total Assets$771
Free Cash Flow-$109K
Debt & Equity
Total Debt$353K
Total Equity-$3.6M
Shares Outstanding
Short Interest
Split History1 split
- 100:1Forward splitFeb 25, 20201 share → 100
Balance Sheet Details
Assets$771
Liabilities$3.6M
Accounts Receivable$0
Accounts Payable$1.09M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 | 2014-08-31 | 2013-08-31 |
| Revenue | $0 | $0 | $0 | $0 | $1K | $1K | $0 | $0 | $0 | $2K | $43K | $28K | $0 | $0 |
| YoY Growth | - | - | - | - | 0.0% | - | - | - | - | -94.8% | 52.0% | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $561 | $561 | $0 | $140 | $264 | $81K | $131K | $109K | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $679 | $679 | $0 | -$140 | -$264 | -$79K | -$88K | -$81K | $0 | $0 |
| Gross Margin | - | - | - | - | 54.8% | 54.8% | - | - | - | -3515.9% | -203.8% | -284.5% | - | - |
| Research and Development | $125K | $181K | $175K | $712K | $280K | $365K | $226K | $0 | $0 | $0 | $4K | $28K | $62K | $10K |
| Selling, General, and Administrative | $320K | $332K | $570K | $660K | $2.35M | $976K | $601K | $121K | $134K | $255K | $201K | $66K | $147K | $40K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | -$482K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $445K | $513K | $745K | $1.37M | $2.63M | $1.34M | $344K | $121K | $134K | $255K | $205K | $94K | $209K | $50K |
| Operating Income (EBIT) | -$445K | -$513K | -$745K | -$1.37M | -$2.63M | -$1.34M | -$344K | -$121K | -$134K | -$334K | -$292K | -$175K | -$209K | -$50K |
| Operating Margin | - | - | - | - | -211825.1% | -108147.7% | - | - | - | -14844.0% | -677.8% | -617.2% | - | - |
| Interest Expense | $80K | $43K | $21K | $2K | $0 | $20K | $0 | $11K | $25K | $4K | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $248 | $0 | $0 | $5 | $31 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$40K | -$54K | $160K | -$2K | $0 | -$20K | -$20K | -$11K | -$42.65M | -$47K | -$3K | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$486K | -$567K | -$585K | -$1.37M | -$2.63M | -$1.34M | -$364K | -$133K | -$42.79M | -$381K | -$296K | -$175K | -$209K | -$50K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $20K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$486K | -$567K | -$585K | -$1.37M | -$2.63M | -$1.34M | -$364K | -$133K | -$42.79M | -$381K | -$296K | -$175K | -$209K | -$50K |
| Net Income Margin | - | - | - | - | -211825.1% | -108092.5% | - | - | - | -16937.8% | -685.2% | -617.2% | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -0.01 | -0.01 | -0.01 | -0.04 | -0.07 | -0.39 | -0.02 | -0.07 | -7736.50 | -68.95 | -49.65 | -29.39 | -38.05 | -5.00 |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -0.04 | -0.07 | -0.39 | -0.02 | -0.07 | -7736.50 | -68.95 | -49.65 | -29.39 | -38.05 | -5.00 |
| Weighted Average OS | 40.07M | 40.07M | 40.07M | 39.23M | 38.92M | 3.42M | 23.18M | 2.06M | 11,041 | 6,017 | 6,019 | 5,959 | 5,490 | 10,000 |
| EBITDA | -$445K | -$513K | -$745K | -$1.35M | $0 | -$1.34M | -$344K | -$121K | -$134K | -$334K | -$292K | -$175K | -$208K | -$50K |
| EBITDA Margin | - | - | - | - | - | -108092.9% | - | - | - | -14832.3% | -676.8% | -615.8% | - | - |
Balance Sheet
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 | 2014-08-31 | 2013-08-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $771 | $4K | $7K | $12K | $145 | $243K | $93 | $93 | $2K | $4K | $7K | $13K | $135K | $80K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $771 | $4K | $7K | $12K | $145 | $243K | $93 | $93 | $2K | $4K | $7K | $13K | $135K | $80K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | -$49K | $0 | $0 | $0 | $13K | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $249K | $0 | $50K | $50 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $771 | $100K | $106K | $261K | $16K | $293K | $93 | $93 | $2K | $4K | $7K | $13K | $135K | $80K |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $140 | $404 | $800 | $932 | $1K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3K | $3K | $4K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3K | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $140 | $3K | $4K | $4K | $5K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $771 | $100K | $106K | $261K | $16K | $293K | $93 | $93 | $2K | $7K | $11K | $18K | $140K | $80K |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $1.09M | $1.34M | $2.5M | $2.45M | $152K | $69K | $12K | $12K | $8K | $3K | $0 | $0 | $6K | $0 |
| Short-Term Debt | $353K | $243K | $143K | $50K | $0 | $0 | $25K | $25K | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | -$1.44M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2K | $1.56M | $0 | -$998K | $507K | -$69K | -$9K | $0 | $2K | $2K | $870 | $7K | $14K | $10K |
| Total Current Liabilities | $4K | $3.2M | $2.67M | $2.51M | $1.09M | $69K | $41 | $41 | $10K | $5K | $870 | $7K | $20K | $10K |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $85K | $85K | $46K | $67K | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6K | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $85 | $85 | $46K | $67K | $0 | $0 | $6K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$6K | $0 |
| Total Liabilities | $3.6M | $3.2M | $2.67M | $2.51M | $1.09M | $69K | $126K | $126K | $55K | $72K | $870 | $7K | $20K | $10K |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $40K | $40K | $40K | $40K | $39K | $34K | $21 | $21 | $21K | $6K | $6K | $6K | $6K | $10K |
| Retained Earnings | -$7.01M | -$6.52M | -$5.95M | -$5.37M | -$4M | -$364K | -$44.03M | -$44.03M | -$43.9M | -$1.11M | -$432K | -$432K | -$257K | -$50K |
| Comprehensive Income & Other | $30K | $89K | $12K | $765 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$400 | $0 | $0 |
| Other Stockholders' Equity | $3.37M | $3.38M | $3.35M | $3.08M | $2.88M | $553K | $43.9M | $43.9M | $43.82M | $1.04M | $436K | $436K | $371K | $120K |
| Total Equity | -$3.6M | -$3.1M | -$2.56M | -$2.25M | -$1.08M | $223K | -$126K | -$126K | -$53K | -$65K | $10K | $10K | $120K | $80K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $771 | $100K | $106K | $261K | $16K | $293K | $93 | $93 | $2K | $7K | $11K | $18K | $140K | $90K |
| Supplementary Data | ||||||||||||||
| Total Debt | $353K | $243K | $143K | $50K | $0 | $0 | $110K | $110K | $46K | $67K | $0 | $0 | $0 | $0 |
| Net Debt | $353 | $239K | $136K | $38K | -$145 | -$243K | $110 | $110 | $44K | $64K | -$7K | -$13K | -$135K | -$80K |
Cash Flow Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 | 2015-08-31 | 2014-08-31 | 2013-08-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$486K | -$567K | -$585K | -$1.37M | -$2.63M | -$1.34M | -$873 | -$133K | -$42.79M | -$381K | -$296K | -$175K | -$209K | -$50K |
| Depreciation & Amortization | $0 | $0 | $0 | $20K | $0 | $0 | $0 | $140 | $264 | $264 | $453 | $387 | $429 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $1.77M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $323K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | -$49K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $438K | $0 | $1.37M | $0 | $26K | $26K | $5K | $5K | $0 | $3K | -$6K | $6K | $0 |
| Other Working Capital | $398K | $4K | $181K | -$1.37M | $34K | $239K | -$50K | $62K | $82K | $0 | -$6K | -$6K | $9K | $10K |
| Total Working Capital Change | $398K | $442K | $181K | $1.15M | $34K | $538K | -$24K | $67K | $87K | $80K | -$4K | -$12K | $15K | $10K |
| Other Non-Cash Items | -$21K | $0 | $294K | $119K | $797K | $381K | -$343K | $4K | $42.65M | $224K | $286K | $0 | $0 | $0 |
| Net Cash from Operating | -$109K | -$125K | -$110K | -$89K | -$25K | -$421K | -$369K | -$62K | -$52K | -$76K | -$13K | -$187K | -$194K | -$40K |
| Investing Activities | ||||||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $17 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $17 | $0 | $0 | $0 | -$10K | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $17 | $17 | $0 | $0 | -$10K | $0 | $0 | -$5K | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | -$110K | - | -$93K | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $50K | $0 | $180K | $612K | $0 | $0 | $0 | $0 | $65K | $252K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $130K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $50K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $110K | $100K | $93K | $100K | $0 | $180K | $612K | $60K | $50K | $89K | $0 | $65K | $252K | $130K |
| Forex Effect | -$6K | $23K | $12K | $765 | $0 | $963K | -$93 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$4K | -$2K | -$6K | $12K | -$2K | -$241K | $243K | -$2K | -$2K | $3K | -$13K | -$122K | $53K | $90K |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$109K | -$125K | -$110K | -$89K | -$25K | -$421K | -$369K | -$62K | -$52K | -$76K | -$13K | -$187K | -$194K | -$40K |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | $4 | $0 | $0 | $0 | $0 | $0 | -$5K | $0 |
| Free Cash Flow | -$109K | -$125K | -$110K | -$89K | -$25K | -$421K | -$369K | -$62K | -$52K | -$76K | -$13K | -$187K | -$199K | -$40K |
| Cash at Beginning | $4K | $7K | $12K | $145 | $2K | $243K | $93 | $2K | $4K | $619 | $13K | $135K | $82K | -$10K |
| Cash at End | $771 | $4K | $7K | $12K | $145 | $2K | $243K | $93 | $2K | $4K | $619 | $13K | $135K | $80K |